Literature DB >> 22081751

Do Research Intermediaries Reduce Perceived Coercion to Enter Research Trials Among Criminally Involved Substance Abusers?

David S Festinger1, Karen L Dugosh, Jason R Croft, Patricia L Arabia, Douglas B Marlowe.   

Abstract

We examined the efficacy of including a research intermediary (RI) during the consent process in reducing participants' perceptions of coercion to enroll in a research study. Eighty-four drug court clients being recruited into an ongoing study were randomized to receive a standard informed consent process alone (standard condition) or with an RI (intermediary condition). Before obtaining consent, RIs met with clients individually to discuss remaining concerns. Findings provided preliminary evidence that RIs reduced client perceptions that their participation might influence how clinical and judicial staff view them. This suggests that using RIs may improve participant autonomy in clinical studies.

Entities:  

Year:  2011        PMID: 22081751      PMCID: PMC3212947          DOI: 10.1080/10508422.2011.570167

Source DB:  PubMed          Journal:  Ethics Behav        ISSN: 1050-8422


  12 in total

1.  The neuropsychological consequences of abstinence among older alcoholics: a cross-sectional study.

Authors:  C A Munro; J Saxton; M A Butters
Journal:  Alcohol Clin Exp Res       Date:  2000-10       Impact factor: 3.455

2.  Protecting research subjects after consent: the case for the "research intermediary.

Authors:  Stanley Joel Reiser; Paula Knudson
Journal:  IRB       Date:  1993 Mar-Apr

3.  Information disclosure, subject understanding, and informed consent in psychiatric research.

Authors:  Paul R Benson; Loren H Roth; Paul S Appelbaum; Charles W Lidz; William J Winslade
Journal:  Law Hum Behav       Date:  1988-12

4.  The ethics of involving psychiatrically impaired persons in research.

Authors:  Evan Gaines DeRenzo
Journal:  IRB       Date:  1994 Nov-Dec

5.  Measuring coercion to participate in research within a doubly vulnerable population: initial development of the coercion assessment scale.

Authors:  Karen Leggett Dugosh; David S Festinger; Jason R Croft; Douglas B Marlowe
Journal:  J Empir Res Hum Res Ethics       Date:  2010-03       Impact factor: 1.742

6.  Declaration of Helsinki. Ethical principles for medical research involving human subjects.

Authors: 
Journal:  J Indian Med Assoc       Date:  2009-06

7.  Improving understanding of research consent disclosures among persons with mental illness.

Authors:  P G Stiles; N G Poythress; A Hall; D Falkenbach; R Williams
Journal:  Psychiatr Serv       Date:  2001-06       Impact factor: 3.084

8.  Alcohol, dementia, and Alzheimer's disease: comparison of neuropsychological profiles.

Authors:  J Saxton; C A Munro; M A Butters; C Schramke; M A McNeil
Journal:  J Geriatr Psychiatry Neurol       Date:  2000       Impact factor: 2.680

9.  Substance dependence, family history of alcohol dependence and neuropsychological functioning in adolescence.

Authors:  S F Tapert; S A Brown
Journal:  Addiction       Date:  2000-07       Impact factor: 6.526

10.  Perceived coercion in mental hospital admission. Pressures and process.

Authors:  C W Lidz; S K Hoge; W Gardner; N S Bennett; J Monahan; E P Mulvey; L H Roth
Journal:  Arch Gen Psychiatry       Date:  1995-12
View more
  3 in total

1.  A qualitative analysis of peer recruitment pressures in respondent driven sampling: Are risks above the ethical limit?

Authors:  Heather I Mosher; Gayatri Moorthi; JiangHong Li; Margaret R Weeks
Journal:  Int J Drug Policy       Date:  2015-06-07

2.  Informed Assent Recall Among Adolescents in Substance Use Disorder Treatment Research.

Authors:  Jordan P Davis; Emily A Lux; Douglas C Smith; Leah Cleeland
Journal:  J Child Adolesc Subst Abuse       Date:  2016-05-04

3.  Achieving new levels of recall in consent to research by combining remedial and motivational techniques.

Authors:  David S Festinger; Karen L Dugosh; Douglas B Marlowe; Nicolle T Clements
Journal:  J Med Ethics       Date:  2013-04-04       Impact factor: 2.903

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.